2021
DOI: 10.3390/ijms221910204
|View full text |Cite
|
Sign up to set email alerts
|

Selective Extracellular Signal-Regulated Kinase 1/2 (ERK1/2) Inhibition by the SCH772984 Compound Attenuates In Vitro and In Vivo Inflammatory Responses and Prolongs Survival in Murine Sepsis Models

Abstract: Sepsis is the leading cause of death in intensive care units worldwide. Current treatments of sepsis are largely supportive and clinical trials using specific pharmacotherapy for sepsis have failed to improve outcomes. Here, we used the lipopolysaccharide (LPS)-stimulated mouse RAW264.7 cell line and AlphaLisa assay for TNFa as a readout to perform a supervised drug repurposing screen for sepsis treatment with compounds targeting epigenetic enzymes, including kinases. We identified the SCH772984 compound, an e… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

1
8
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
4
2

Relationship

1
5

Authors

Journals

citations
Cited by 11 publications
(9 citation statements)
references
References 65 publications
1
8
0
Order By: Relevance
“…Several large-scale transcriptomic and proteomic studies have been performed with macrophages challenged with LPS with the aim of exploring different aspects of the TLR4 signaling and its impact on mucosal protection [ 40 , 41 ]. In this work, we carried out a transcriptomic study to evaluate the response of murine macrophages to the activation of TLR4 and in line with several other studies [ 51 , 52 ], we found that RAW macrophages mount a complex transcriptomic response characterized by changes in the expression of hundreds of genes with diverse immunological functions. Of note, the most remarkable changes in RAW macrophages after the stimulation with LPS were found in expression of cytokines, chemokines and surface markers genes.…”
Section: Discussionsupporting
confidence: 63%
“…Several large-scale transcriptomic and proteomic studies have been performed with macrophages challenged with LPS with the aim of exploring different aspects of the TLR4 signaling and its impact on mucosal protection [ 40 , 41 ]. In this work, we carried out a transcriptomic study to evaluate the response of murine macrophages to the activation of TLR4 and in line with several other studies [ 51 , 52 ], we found that RAW macrophages mount a complex transcriptomic response characterized by changes in the expression of hundreds of genes with diverse immunological functions. Of note, the most remarkable changes in RAW macrophages after the stimulation with LPS were found in expression of cytokines, chemokines and surface markers genes.…”
Section: Discussionsupporting
confidence: 63%
“…43 Previous research has reported that the effective dose range of SCH772984 in mouse models is 10-20 mg/kg. [44][45][46] In conclusion, 1 mg/kg psilocin counteracted METH-induced hy-…”
Section: Discussionmentioning
confidence: 82%
“…SCH772984 is a selective ERK1/2 inhibitor that binds to unphosphorylated and inactive ERK1/2 and effectively inhibits ERK1/2 phosphorylation 43 . Previous research has reported that the effective dose range of SCH772984 in mouse models is 10–20 mg/kg 44–46 …”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Reactome PK buffer and TRIzol RNA-seq data analysis of LPS-induced DEGs for each organ identified nearly identical pathways well described in models of sepsis (48,50,58). This included such pathways as cytokine signaling in the immune system, neutrophil degranulation, signaling by interleukins, platelets degranulation and several others ( Fig.8C ).…”
Section: Resultsmentioning
confidence: 90%